|
|
|
|
LEADER |
00000cam a2200000Mu 4500 |
001 |
EBSCO_on1003261866 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr |n|---||||| |
008 |
170909s2017 xx ob 001 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCO
|d OCLCQ
|d YDX
|d N$T
|d OCLCF
|d IGB
|d AUW
|d BTN
|d MHW
|d INTCL
|d SNK
|d G3B
|d S8I
|d S8J
|d S9I
|d STF
|d D6H
|d OCLCQ
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 995357828
|a 996416912
|a 999474336
|a 1264911190
|
020 |
|
|
|a 9781536123906
|
020 |
|
|
|a 1536123900
|
020 |
|
|
|z 1536123722
|
020 |
|
|
|z 9781536123722
|
035 |
|
|
|a (OCoLC)1003261866
|z (OCoLC)995357828
|z (OCoLC)996416912
|z (OCoLC)999474336
|z (OCoLC)1264911190
|
050 |
|
4 |
|a RC280.B8
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99449
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Montgomery, Marion.
|
245 |
1 |
0 |
|a Triple-Negative Breast Cancer.
|
260 |
|
|
|a Hauppauge :
|b Nova Science Publishers, Inc.,
|c 2017.
|
300 |
|
|
|a 1 online resource (132 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Cancer Etiology, Diagnosis and Treatments
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Preface; Chapter 1; The Role of Exosomes in Breast Cancer: What Have We Learned in Ten Years?; Abstract; Introduction; Exosomes: An Overview; Exosomes: In Cancer; Cancer-Associated Exosomes Containing Proteins; Cancer-Associated Exosomes Containing Nucleic Acids; miRNA-containing Exosomes; mRNA-Containing Exosomes; DNA-containing Exosomes; Cancer-Associated Exosomes Containing Lipids; Exosomes in the Breast Tumor Microenvironment; Exosomes in Hypoxia, Epithelial -- Mesenchymal Transition, ROS Production and Autophagy; Exosomes in Metastasis; Exosomes and Drug Resistance.
|
505 |
8 |
|
|a Conclusion and Future PerspectivesReferences; Chapter 2; Correlations between BRCA Gene Mutations and the High Risk of TNBC as Defined by the Defect of Estrogen Signaling; Abstract; Introduction; Interplay Between Endogenous Estrogens and Wild-Type BRCA Genes; Correlations between BRCA Gene Mutations and Defective Estrogen Signaling; Decreased ER-Alpha Expression in BRCA Gene Mutation Carrier Cells; Decreased Estradiol-Liganded Transcriptional Activity of ERs in BRCA Gene Deficient Cells; Defensive Counteractions Against BRCA Gene Defects.
|
505 |
8 |
|
|a Increased Aromatase Activity Associated with BRCA Gene MutationHyperestrogenism as a Compensatory Mechanism in Women with BRCA Gene Mutation; Increased Ligand-Independent Transcriptional Activity in Cells with BRCA1 Mutation; Hormonal Risk Factors for Overall Breast Cancer and TNBC; Correlations between Menopausal Status and TNBC Risk; Correlations between Reproductive History and the Risk of Different Breast Cancer Subtypes; Conclusion; References; Chapter 3; The Role of Tumor Infiltrating Lymphocytes (TILs) in Triple Negative Breast Cancer (TNBC); Abstract; Introduction.
|
505 |
8 |
|
|a Pathologic and Molecular Heterogeneity of TNBCTumor-Infiltrating Lymphocytes in TNBC; a. TILs as a Prognostic Factor; b. TILs as a Predictive Factor; c. TILs as Biomarkers of Residual Disease; Targeting the Immune System in Triple-Negative Breast Cancer: Potential Role of the PD-1/PD-L1 Pathway as a Biomarker; Conclusion; References; Index; Blank Page.
|
504 |
|
|
|a Includes bibliographical references and index.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Breast
|x Cancer.
|
650 |
|
2 |
|a Breast Neoplasms
|
650 |
|
6 |
|a Sein
|x Cancer.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Breast
|x Cancer.
|2 fast
|0 (OCoLC)fst00838260
|
776 |
0 |
8 |
|i Print version:
|a Montgomery, Marion.
|t Triple-Negative Breast Cancer: Biomarkers, Emerging Therapeutic Strategies and Clinical Challenges.
|d Hauppauge : Nova Science Publishers, Inc., ©2017
|z 9781536123722
|
830 |
|
0 |
|a Cancer etiology, diagnosis, and treatments.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1562819
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4938668
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 1562819
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 14716707
|
994 |
|
|
|a 92
|b IZTAP
|